Nanotechnology in vaccine delivery - PMC
With very few adjuvants currently being used in marketed human vaccines, a critical need exists for novel immunopotentiators and delivery vehicles capable of eliciting humoral, cellular and mucosal immunity. Such crucial vaccine components could facilitate ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103321/
In response None None to his Publication
Thank you!! I'm very interested in reading this. Also, will repost! 💝
Aware of enough lies that I am suspicious of every truth - and the truth does not care about your feelings...INFJ Sigma
In response Patriot AztekJade to her Publication
Most welcome